Recent Updates
Recently added Catalysts
INDV Positive Sentiment

Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th

Thursday, October 16, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Indivior PLC has announced it will report its third quarter 2025 financial results on October 30, 2025. Following the results, CEO Joe Ciaffoni and the leadership team will host a live webcast presentation. The event aims to keep investors informed about the company's financial performance and ongoing commitment to treating opioid use disorder.
Price reaction · baseline $24.69 (2025-10-16 close) · hit after-hours · clean, no other INDV news in the window
day 0 close
-0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Indivior is actively engaging with investors through a webcast.
  • The company is focused on addressing opioid use disorder, a significant health issue.
  • The upcoming financial results may provide insights into the company's performance.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
5.4%
average across 2 past catalysts
Lead asset
RBP-6000
Phase 3 · Opioid Use Disorder

Full Press Release Details

RICHMOND, Va.,Oct. 16, 2025/PRNewswire/ -- Indivior PLC (Nasdaq:INDV) today announced that it will report its third quarter 2025 financial results on Thursday, October 30, 2025, at 7:00 a.m. U.S. ET. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior's leadership team will host a presentation via live webcast at 8:00 a.m. U.S. ET.

Access to the Live Webcast Presentation:

The webcast event and materials can be accessed on the "Investors" section of the company's website atwww.indivior.combefore the event begins.

Live Q3 2025 webcast link:https://edge.media-server.com/mmc/p/gtkfqvez

Participants may access the presentation telephonically by registering with the following link:

https://register-conf.media-server.com/register/BI470cbb79a42846d5b6b180de536bbf66

(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
A replay of the presentation will be available atwww.indivior.com.

About IndiviorIndivior Pharmaceuticals works to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a human crisis to a recognized and treated chronic disease. Building on its portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Visitwww.indivior.comto learn more. Connect with Indivior on LinkedIn by visitingwww.linkedin.com/company/Indivior.

Frequently Asked Questions

When will Indivior report its Q3 2025 financial results?

Indivior will report its Q3 2025 financial results on October 30, 2025.

Who will host the webcast presentation?

CEO Joe Ciaffoni and Indivior's leadership team will host the webcast.

How can I access the live webcast?

The live webcast can be accessed via the Investors section of Indivior's website.

What is Indivior's focus in the pharmaceutical industry?

Indivior focuses on developing medicines to treat opioid use disorder.

ShareAdd on Google
Tags: INDV Viatris Investor Conferences Healthcare Indivior financial results webcast opioid use disorder
Last updated: Oct 16, 2025

Biotech snapshot

Cash runway
$222M liquidity · $0M/mo burn
Low dilution risk
Lead asset
RBP-6000Phase 3
Opioid Use Disorder →

Catalyst track record

+35%
best trade around INDV's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for INDV.

See every catalyst's timing & PoA →